Group One Trading
ALZN icon

Group One Trading’s Alzamend Neuro ALZN Stock Holding History

Group One Trading’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$4.69K – 7591
2023
Q2 		$4.69K Hold
7
– – ﹤0.01% 6747
2023
Q1 		$4.04K Hold
7
– – ﹤0.01% 6372
2022
Q4 		$5.65K Sell
7
-13
-65% -$18.8K ﹤0.01% 6287
2022
Q3 		$32K Sell
20
-1
-5% -$1.37K ﹤0.01% 5742
2022
Q2 		$24K Buy
21
+9
+75% +$11.7K ﹤0.01% 6134
2022
Q1 		$20K Sell
12
-58
-83% -$109K ﹤0.01% 6734
2021
Q4 		$180K Buy
70
+65
+1,300% +$201K ﹤0.01% 5191
2021
Q3 		$20K Buy
+5
New +$27.5K ﹤0.01% 7163

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's ALZN Position: Q3 2023 in Review

Group One Trading sold out of Alzamend Neuro (ALZN) in Q3 2023, closing a stake of 4 shares — an estimated $1.91K sold.

Group One Trading first reported a position in ALZN in Q3 2021 and held it in 7 quarters. The position peaked at $82K in Q4 2021. 22 funds tracked by Wall St. Rank hold ALZN as of Q3 2023.

  • Group One Trading reported no remaining Alzamend Neuro position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 4 Alzamend Neuro shares in Q3 2023, an estimated $1.91K.
  • Group One Trading first reported a position in Alzamend Neuro in Q3 2021 and held it in 7 quarters.
  • Group One Trading's Alzamend Neuro position peaked at $82K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.